ENT Disorder Treatment Market To Reach $4.5 Billion, Globally, by 2031 at 6.5% CAGR: Cipla, AurbindoPharma, Teva Pharmaceuticals, Bayer AG, Amneal Pharmaceuticals Ltd, M.M Pharma

The rise in the prevalence of chronidc diseases such as sinusitis and chronic rhinitis across the world and rise in healthcare expenditure in developing countries are the key factors that boost the market growth.

The global ENT disorder treatment industry generated $2.4 billion in 2021, and is estimated to reach $4.5 billion by 2031, witnessing a CAGR of 6.5% from 2022 to 2031.

The rise in the prevalence of diseases like sinusitis and chronic rhinitis across the world further drives the growth of the market. In addition, the rise in healthcare expenditure and the increase in government initiatives in developing countries are the ENT Disorder Treatment Market trends that further boost the market growth.

Download Free Sample Report:
https://www.alliedmarketresearch.com/request-sample/3827

Covid-19 Scenario

The COVID-19 pandemic positively impacted the growth of the global ENT disorder treatment market, owing to the prevalence of the coronavirus disease which is mainly associated with the nose and throat infection.

According to the National Center for Biotechnology Information, COVID-19 disease is primarily characterized by symptoms of the lower respiratory tract, such as fever, coughing, dyspnea, and tightness in the chest, which may advance quickly to acute respiratory distress syndrome (ARDS).

Moreover, Covid-19 causes different upper respiratory tract related symptoms including nasal congestion, sore throat and smell dysfunction. Such factors boosted the growth of the global ENT disorder treatment market.

By organ, the ENT disorder treatment market is segmented into ear, nose and throat. The nose segment was the highest revenue contributor to the market, owing to the rise in the prevalence of allergic rhinitis and increase in the prevalence of viral infection across the world.

The throat segment is expected to grow at a considerable growth rate during the ENT disorder treatment market forecast period owing to increase in number of patient suffering from chronic tonsillitis across the world.

Purchase Inquiry:

https://www.alliedmarketresearch.com/purchase-enquiry/3827

The hospitals and clinics segment to maintain its dominance during the forecast period

Based on end user, the hospitals and clinics segment held the largest share of more than two-fifths of the global ENT disorder treatment market in 2021, and is likely to maintain a noteworthy growth during the forecast period. Moreover, the same segment is likely to exhibit the highest CAGR of 7.4% in 2031. The increase in the prevalence of infectious and allergic disorders such as sinusitis, tonsillitis, ear infection, nasal airway obstruction, and growing number of ENT patients visiting hospitals propel the growth of the segment.

The key players that operate in the ENT disorder treatment market are Sanofi, Novartis, GSK, Pfizer, Vitaris, Sun Pharma, AstraZeneca, Cipla, AurbindoPharma, Teva Pharmaceuticals, Bayer AG, Amneal Pharmaceuticals Ltd, M.M Pharma, Lyra Therapeutics, Lannet Company Inc.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Blood Bank Information Systems Market https://www.alliedmarketresearch.com/blood-bank-information-systems-market-A13428

Plant Tissue Culture Market https://www.alliedmarketresearch.com/plant-tissue-culture-market-A14265

Human Papillomavirus Vaccine Market https://www.alliedmarketresearch.com/human-papillomavirus-vaccine-market-A14328

Cell Line and Membrane Market https://www.alliedmarketresearch.com/cell-line-and-membrane-market-A13858

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.